Dr. Weiss Discusses Current Clinical Trials in Head and Neck Cancer

Partner | Cancer Centers | <b>UNC LINEBERGER</b>

Jared Weiss, MD, assistant professor, UNC Lineberger Comprehensive Cancer Center, discusses current clinical trials in head and neck cancer.

Jared Weiss, MD, assistant professor, UNC Lineberger Comprehensive Cancer Center, discusses current clinical trials in head and neck cancer.

Currently, Weiss is involved in a clinical trial incorporating immunotherapy with radiation—which has investigators from various cancer centers hopeful that this regimen could be a replacement for cisplatin, with a higher cure rate and less toxicities.

There is also a study that combines durvalumab (Imfinzi) carboplatin and nab-paclitaxel as induction therapy prior to surgery for hard-to-treat patients.